Table 1 Baseline characteristics of participants in the Malmö Preventive Project (MPP) stratified by sex
All | Men | Women | |
|---|---|---|---|
Sex, men n (%) | 33,335 | 22,433 (67.3) | 10,902 (32.7) |
Age* (years) | 45.7 (7.4) | 43.7 (6.6) | 49.7 (7.4) |
BMI (kg/m2) | 24.6 (3.6) | 24.7 (3.3) | 24.4 (4.2) |
Serum urate (micromol/L) | 300.8 (70.1) | 323.2 (64.2) | 254.4 (57.8) |
Seum urate > 405, n (%) | 2455 (7.1%) | 2191 (9.8%) | 164 (1.5%) |
SBP in individuals with non-treated hypertension at baseline (mmHg)** | 149 (21) | 150 (20) | 148 (21) |
Fasting glucose (millimol/L) in non-DM individuals at baseline | 4.9 (0.5) | 4.9 (0.5) | 4.8(0.5) |
eGFR (ml/min/1.73m2) | 77.9 (10.8) | 79.1 (10.5) | 75.6 (10.9) |
Cholesterol (milimol/L) | 5.7 (1.1) | 5.6 (1.1) | 5.8 (1.1) |
Triglycerides (milimol/L) | 1.4 (0.9) | 1.5 (1.1) | 1.1(0.6) |
Hypertension at baseline n (%)§ | 6070 (17.2) | 3672 (16.4) | 2398 (22) |
Diabetes mellitus at baseline, n (%)§§ | 828 (2.5) | 575 (2.6) | 253 (2.3) |
Family history of any sibling having hypertension, n (%) | 2519 (7.6) | 1102 (4.9) | 1417 (13) |
History of kidney stone attack, n (%) | 2729 (8.2) | 2003 (8.9) | 726 (6.7) |
History of several kidney stone attacks, n (%) | 1359 (4.1) | 1046 (4.7) | 313 (2.9) |
Mm-MAST ≥ 2, n (%)# | 21.7 | 30.8 | 2.8 |
ESR (mm/hour) | 7.1 (6.9) | 5.7 (6.0) | 9.9 (7.7) |
Current smoker, n (%) | 14,846 (44.5) | 11,038 (49.2) | 3808 (37.1) |